Drugs / Seasonal trivalent influenza vaccine (TIV)
Seasonal trivalent influenza vaccine (TIV)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00985673 | Oct → Dec 2009 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal trivalent influenza vaccine (TIV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00985673 ↗ |
| Modality | Vaccine | “Co-administered With Trivalent Inactivated Seasonal Influenza Vaccine in Adults 19 to 40 Years of Age” NCT00985673 ↗ |